Results 21 to 30 of about 479,340 (207)

Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance

open access: yesViruses, 2023
Hepatitis B surveillance is essential to achieving Canada’s goal of eliminating hepatitis B by 2030. Hepatitis B rates, association of infection with vaccine age-eligibility, and risk factors were analyzed among 1,401,603 first-time Canadian blood donors
Sheila F. O’Brien   +9 more
doaj   +1 more source

Depressive symptoms and cognitive dysfunctions in patients with chronic hepatitis B [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2015
Introduction. Pronounced symptoms of depression and disorders of cognitive functions can be observed in patients with chronic hepatitis B. Objective.
Pavić Slađana   +3 more
doaj   +1 more source

Clinical trial of lamivudine in children with chronic hepatitis B. [PDF]

open access: yes, 2002
N Engl J Med. 2002 May 30;346(22):1706-13. Clinical trial of lamivudine in children with chronic hepatitis B. Jonas MM, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR, Greensmith MJ, Gardner SD, Bell MS, Sokal EM; International Pediatric ...
Areias, J.A.   +10 more
core   +1 more source

Baseline quantitative HBcAb strongly predicts undetectable HBV DNA and RNA in chronic hepatitis B patients treated with entecavir for 10 years

open access: yesScientific Reports, 2021
The predictive effect of quantitative anti-hepatitis B core on double-negative HBV DNA and RNA remains unstudied. We observed dynamic changes in this measure in chronic hepatitis B patients receiving entecavir for 10 years, evaluating its predictive ...
Xi Zhang   +8 more
doaj   +1 more source

CLINICAL RELEVANCE OF PRECORE MUTATIONS OF HEPATITIS B VIRUS IN CHRONIC LIVER DISEASE [PDF]

open access: yes, 2014
Introduction: Hepatitis B is one of the most frequent etiological factors for chronic liver diseases worldwide. Recent studies have suggested the important role of the genetic diversity of the virus on natural course of hepatitis B. Hepatitis B e-antigen
Chaloska Ivanova Viktorija   +4 more
core   +2 more sources

Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy

open access: yesmBio
The persistence of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is a key obstacle for HBV cure. This study aims to comprehensively assess the effect of interferon (IFN) and small-interfering RNA (siRNA) combination on the cccDNA ...
Kongying Hu   +10 more
doaj   +1 more source

Prevention of Hepatitis B Virus Transmission in Pregnancy [PDF]

open access: yes, 2014
Chronic hepatitis B virus infection is a serious health problem in many countries, particularly in developing countries. In Asia-Pacific region, vertical transmission from mother to child is the main endemicity factor of hepatitis B virus (HBV) infection.
Praptiwi, D. R. (Dwi)   +1 more
core   +1 more source

An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes

open access: yesEmerging Microbes and Infections
Type I interferons (IFN-Is) have key roles in immune defense and treatments for various diseases, including chronic hepatitis B virus (HBV) infection.
Yumeng Li   +10 more
doaj   +1 more source

Prevention of Hepatitis B Vertical Transmission: Focus on Antenatal Antiviral Administration

open access: yesJurnal Penyakit Dalam Indonesia, 2016
Hepatitis B is one of the main cause of chronic liver disease, and potentially cause cirrhosis, liver failure and hepatocellular carcinoma in 15-40% population. Globally, 2 billion people are infected by Hepatitis B.
Anandhara Indriani Khumaedi   +2 more
doaj   +1 more source

Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets [PDF]

open access: yes, 2011
It has been shown that infection of GB virus B (GBV-B), which is closely related to HCV, develop acute self-resolving hepatitis in tamarins. In this study we sought to examine longitudinally the dynamics of viral and immunological status following GBV-B
Yuki Iwasaki   +18 more
core   +1 more source

Home - About - Disclaimer - Privacy